Insufficient scRNA-seq data for expression of ULBP3 at single-cell level.
Insufficient scRNA-seq data for expression of ULBP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 98% | 48.69 | 638 / 653 | 91% | 15.24 | 549 / 605 |
lung | 79% | 20.04 | 459 / 578 | 88% | 8.31 | 1022 / 1155 |
bladder | 62% | 10.81 | 13 / 21 | 88% | 6.99 | 441 / 504 |
kidney | 75% | 14.62 | 67 / 89 | 72% | 4.09 | 652 / 901 |
adrenal gland | 95% | 40.00 | 246 / 258 | 49% | 2.65 | 113 / 230 |
esophagus | 47% | 16.94 | 681 / 1445 | 95% | 10.97 | 174 / 183 |
stomach | 59% | 10.87 | 211 / 359 | 82% | 5.76 | 234 / 286 |
uterus | 51% | 6.73 | 86 / 170 | 87% | 9.72 | 399 / 459 |
pancreas | 47% | 5.72 | 153 / 328 | 89% | 4.98 | 159 / 178 |
intestine | 38% | 5.31 | 370 / 966 | 92% | 6.53 | 486 / 527 |
ovary | 56% | 11.11 | 100 / 180 | 72% | 3.91 | 310 / 430 |
breast | 92% | 38.17 | 423 / 459 | 35% | 2.38 | 390 / 1118 |
skin | 65% | 62.55 | 1175 / 1809 | 35% | 2.00 | 167 / 472 |
adipose | 92% | 35.95 | 1102 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 7.39 | 38 / 45 |
brain | 46% | 9.47 | 1215 / 2642 | 29% | 1.58 | 207 / 705 |
prostate | 28% | 3.22 | 69 / 245 | 33% | 1.03 | 167 / 502 |
blood vessel | 55% | 9.14 | 740 / 1335 | 0% | 0 | 0 / 0 |
heart | 48% | 8.33 | 413 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 41% | 1.48 | 12 / 29 |
liver | 25% | 4.35 | 57 / 226 | 14% | 0.68 | 57 / 406 |
spleen | 39% | 4.51 | 94 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 30% | 0.98 | 24 / 80 |
muscle | 15% | 1.64 | 118 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 11% | 1.23 | 106 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0030101 | Biological process | natural killer cell activation |
GO_0002476 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
GO_0002486 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent |
GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
GO_0042267 | Biological process | natural killer cell mediated cytotoxicity |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0046703 | Molecular function | natural killer cell lectin-like receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ULBP3 |
Protein name | UL16-binding protein 3 (ALCAN-gamma) (NKG2D ligand 3) (N2DL-3) (NKG2DL3) (Retinoic acid early transcript 1N) |
Synonyms | RAET1N N2DL3 |
Description | FUNCTION: Binds and activates the KLRK1/NKG2D receptor, mediating natural killer cell cytotoxicity. . |
Accessions | ENST00000367339.7 ENST00000438272.2 Q9BZM4 |